Neuburgh Advisers’s Globus Medical GMED Stock Holding History

Neuburgh Advisers’s Portfolio GMED Stock Details GMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	$342K	Hold	6,688	–	–	0.01%	556
2019 Q2	$283K	Hold	6,688	–	–	0.01%	604
2019 Q1	$330K	Hold	6,688	–	–	0.01%	550
2018 Q4	$289K	Hold	6,688	–	–	0.01%	542
2018 Q3	$380K	Buy	6,688 +1,280	+24%	+$67.4K	0.01%	547
2018 Q2	$273K	Hold	5,408	–	–	0.01%	572
2018 Q1	$269K	Hold	5,408	–	–	0.01%	569
2017 Q4	$222K	Buy	5,408 +832	+18%	+$29.1K	0.01%	628
2017 Q3	$136K	Buy	4,576 +576	+14%	+$17.6K	0.01%	699
2017 Q2	$133K	Buy	4,000 +1,808	+82%	+$56.8K	0.01%	665
2017 Q1	$65K	Buy	+2,192	New	+$59.8K	﹤0.01%	712

Other funds holding GMED

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

GKIM

GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

Neuburgh Advisers's GMED Position: Q3 2019 in Review

Neuburgh Advisers held its Globus Medical (GMED) position steady in Q3 2019 at 6,688 shares worth $342K. The position accounts for 0.01% of the portfolio, ranked #556.

Neuburgh Advisers first reported a position in GMED in Q1 2017 and has held it in 11 quarters since. The position peaked at $380K in Q3 2018. 268 funds tracked by Wall St. Rank hold GMED as of Q3 2019.

Neuburgh Advisers held 6,688 shares of Globus Medical worth $342K as of Q3 2019.
Neuburgh Advisers left its Globus Medical share count unchanged in Q3 2019.
Globus Medical made up 0.01% of Neuburgh Advisers's portfolio in Q3 2019, its #556 holding.
Neuburgh Advisers first reported a position in Globus Medical in Q1 2017 and has held it in 11 quarters since.
Neuburgh Advisers's Globus Medical position peaked at $380K in Q3 2018.
268 funds tracked by Wall St. Rank held Globus Medical as of Q3 2019.

Based on Neuburgh Advisers's 13F filing for Q3 2019, filed 14 Nov 2019.